The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Review article: the clinical pharmacology of proton pump inhibitors
Open accessAbstract
Summary: Proton pump inhibitors inhibit the gastric H+/K+‐ATPase via covalent binding to cysteine residues of the proton pump. All proton pump inhibitors must undergo acid accumulation in the parietal cell through protonation, followed by activation mediated by a second protonation at the active secretory canaliculus of the parietal cell. The relative ease with which these steps occur with different proton pump inhibitors underlies differences in their rates of activation, which in turn influence the location of covalent binding and the stability of inhibition. Slow activation is associated with binding to a cysteine residue involved in proton transport that is located deep in the membrane. However, this is inaccessible to the endogenous reducing agents responsible for restoring H+/K+‐ATPase activity, favouring a longer duration of gastric acid inhibition. Pantoprazole and tenatoprazole, a novel proton pump inhibitor which has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors, are activated more slowly than other proton pump inhibitors but their inhibition is resistant to reversal. In addition, tenatoprazole has a greatly extended plasma half‐life in comparison with all other proton pump inhibitors. The chemical and pharmacological characteristics of tenatoprazole give it theoretical advantages over benzimidazole‐based proton pump inhibitors that should translate into improved acid control, particularly during the night.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux Disease
Bell, N. J. V., Burget, D., Howden, C. W., Wilkinson, J., & Hunt, R. H. (1992) · Digestion · doi:10.1159/000200917 · Cited by 542
Self-citationEsomeprazole (40 Mg) Compared With Lansoprazole (30 Mg) in The Treatment of Erosive Esophagitis
Castell, D. O., Kahrilas, P. J., Richter, J. E., Vakil, N. B., Johnson, D., Zuckerman, S., Skammer, W., & Levine, J. G. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04094-1 · Cited by 436
Richter, J. E., Kahrilas, P. J., Johanson, J., Maton, P., Breiter, J. R., Hwang, C., Marino, V., Hamelin, B., Levine, J. G., & Esomeprazole Study Investigators* (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03600.x · Cited by 394
Kahrilas, P. J., Falk, G. W., Johnson, D. A., Schmitt, C., Collins, D. W., Whipple, J., D'Amico, D., Hamelin, B., Joelsson, B., & FOR THE ESOMEPRAZOLE STUDY INVESTIGATORS (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00856.x · Cited by 349
Is there an optimal degree of acid suppression for healing of duodenal ulcers?
Burget, D. W., Chiverton, S. G., & Hunt, R. H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91015-x · Cited by 340
The mechanism of action of the antisecretory agent omeprazole
Lindberg, P., Nordberg, P., Alminger, T., Braendstroem, A., & Wallmark, B. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00158a001 · Cited by 305
Chemistry of Covalent Inhibition of the Gastric (H+, K+)-ATPase by Proton Pump Inhibitors
Shin, J. M., Cho, Y. M., & Sachs, G. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049607w · Cited by 283
Self-citationSites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol Reagents
Besancon, M., Simon, A., Sachs, G., & Shin, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22438 · Cited by 259
Self-citationPotassium-competitive acid blockade: A new therapeutic strategy in acid-related diseases
Andersson, K., & Carlsson, E. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.005 · Cited by 202
Besancon, M., Shin, J. M., Mercier, F., Munson, K. B., Miller, M., Hersey, S., & Sachs, G. M. (1993) · Biochemistry · doi:10.1021/bi00060a028 · Cited by 136
Self-citation
Cited by
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
Baumann, M., & Baxendale, I. R. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.265 · Cited by 841
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Strand, D. S., Kim, D., & Peura, D. A. (2017) · Gut and Liver · doi:10.5009/gnl15502 · Cited by 671
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shi, S., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0538-y · Cited by 314
Metadata
- Authors
- SACHS, G., SHIN, J. M., & HOWDEN, C. W.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2006-05-15
- Volume
- 23
- Issue
- s2
- Pages
- 2-8
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2147199669
- Cited by
- 407
- References
- 25
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: the clinical pharmacology of proton pump inhibitors. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.02943.x
- The paper
- SACHS, G., SHIN, J. M., & HOWDEN, C. W. (2006). Review article: the clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.02943.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.